Ligand validation:4NJU

TPV: N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE

TPV is a Ligand Of Interest in 4NJU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4NJU_TPV_A_500	85%	19%	0.087	0.953	1.2	2.22	2	12	0	0	100%	1
4NJU_TPV_C_500	82%	19%	0.092	0.946	1.24	2.21	3	13	0	0	100%	1
3SPK_TPV_A_100	91%	27%	0.082	0.967	1.42	1.53	5	5	16	0	100%	0.5
6DIF_TPV_B_201	79%	7%	0.109	0.953	2.92	1.94	12	15	0	0	100%	0.7
6DIL_TPV_B_201	55%	5%	0.152	0.919	3.35	2.03	11	17	0	0	100%	0.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.